diclofenac has been researched along with Graves Ophthalmopathy in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloise, W | 1 |
Mimura, LY | 1 |
Moura, J | 1 |
Nicolau, W | 1 |
Vondrichova, T | 1 |
de Capretz, A | 1 |
Parikh, H | 1 |
Frenander, C | 1 |
Asman, P | 1 |
Aberg, M | 1 |
Groop, L | 1 |
Hallengren, B | 1 |
Lantz, M | 1 |
2 other studies available for diclofenac and Graves Ophthalmopathy
Article | Year |
---|---|
Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study.
Topics: Adult; Aged; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Graves Ophthalmopathy; Humans; Male; M | 2011 |
COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
Topics: Adipocytes; Adipogenesis; Cell Differentiation; Cyclooxygenase 2; Dexamethasone; Diclofenac; Gene Ex | 2007 |